3Q11 US Lovenox Sales by Product and Market Segment (estimated) [pre] -$ Sales (mln)- -----Share----- Branded Generic Branded Generic Hospital segment 159 107 60% 40% Outpatient segment 25 152 14% 86% ================== === === Overall market 184 259 42% 58%[/pre] Assumptions: 1. The hospital segment comprises 60% of the market by dollar sales. 2. Sales in the outpatient setting are proportional to scripts (#msg-66940914). (2Q11 numbers are shown in #msg-65934604.)